Metagenomi Therapeutics
69 hedge funds and large institutions have $10.4M invested in Metagenomi Therapeutics in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 20 increasing their positions, 20 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $13.2M → $10.4M (-$2.78M)
31% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 26
Holders
69
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.08M | |
| 2 | +$310K | |
| 3 | +$249K | |
| 4 |
PLC
Peapod Lane Capital
Bedford Hills,
New York
|
+$244K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$235K |
Top Sellers
| 1 | -$1.95M | |
| 2 | -$1.2M | |
| 3 | -$683K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$511K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$312K |